CoChat

Identification of Risk Factors for Elevated Transaminases in Methotrexate Users Through an Electronic Health Record

Schmajuk, Gabriela, Miao, Yinghui, Yazdany, Jinoos, Boscardin, W. John, Daikh, David I., Steinman, Michael A. · 2014 · Arthritis Care & Research
Cited by 69

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Objective: To determine the predictors of elevated transaminases in an incident user cohort of older adult patients with rheumatic diseases receiving methotrexate (MTX) using elements derived from an electronic health record. Methods: Using a national, administrative database of patients seen through the Veterans Health Administration that included pharmacy and laboratory data, we performed an observational cohort study of veterans ages ≥65 years who were new users of MTX to identify risk factors for elevated transaminases. Results: We studied 659 incident users of MTX. We found a 6% incidence of moderate (≥1.5 × the upper limit of normal) elevations in aspartate aminotransferase or alanine aminotransferase over a mean followup period of 7 months. We identified predictors of moderate transaminase elevations to include obesity (per body mass index ≥30 kg/m 2), total cholesterol >240 mg/dl, pre‐MTX liver function test (LFT) elevations, use of biologic agents, and lack of folic acid supplementation. A patient with these characteristics and >3 comorbid conditions would be predicted to have a 90% chance of developing a moderate transaminase elevation in the 7 months after starting MTX. Conclusion: Moderate LFT abnormalities were uncommon in the first 7 months of MTX use, but were more likely to occur in patients with obesity, untreated high cholesterol, pre‐MTX LFT elevations, biologic agent use, and lack of folic acid supplementation. Future work should aim to develop a robust, automated prediction rule for identifying patients at high risk for MTX‐related liver toxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/acr.22294

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. Sokka T, 2010, Increases in use of methotrexate since the 1980s, Clin Exp Rheumatol, 28, S13
  2. Davis SA, 2013, Combination therapy for psoriasis in the United States, J Drugs Dermatol, 12, 546
  3. Visser K, 2009, Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature, Clin Exp Rheumatol, 27, 1017
  4. 10.1002/art.23721 · DOI · Paper page
  5. Kent PD, 2004, Risk factors for methotrexate‐induced abnormal laboratory monitoring results in patients with rheumatoid arthritis, J Rheumatol, 31, 1727
  6. 10.1136/ard.2009.112136 · DOI
  7. 10.1002/art.30155 · DOI · Paper page
  8. 10.1111/j.1532-5415.2012.04158.x · DOI · Paper page
  9. 10.1186/1472-6963-7-54 · DOI
  10. 10.1097/00005650-199306000-00003 · DOI · Paper page
  11. 10.1177/106286060401900504 · DOI · Paper page
  12. 10.1016/0895-4356(92)90133-8 · DOI · Paper page
  13. 10.1056/NEJMra052270 · DOI · Paper page
  14. Harrell FE, 1996, Tutorial in biostatistics, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med, 15, 361
  15. Kremer JM, 1996, Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis, J Rheumatol, 23, 459
  16. 10.1097/MLR.0b013e3181ef60d9 · DOI · Paper page
  17. 10.1111/j.1475-6773.2010.01126.x · DOI · Paper page
  18. 10.1002/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7 · DOI · Paper page
  19. 10.1371/journal.pone.0004435 · DOI
  20. 10.1002/hep.23784 · DOI · Paper page
  21. 10.1002/anr.1780320202 · DOI · Paper page
  22. 10.1016/j.jhep.2006.05.008 · DOI
  23. 10.1002/acr.20629 · DOI · Paper page
  24. 10.1136/ard.62.9.842 · DOI · Paper page
  25. 10.1002/pds.1454 · DOI
  26. 10.1097/MD.0b013e318211106a · DOI · Paper page
  27. 10.1136/ard.49.8.591 · doi:10.1136/ard.49.8.591

Cited by

See all 69

Metadata

Authors
Schmajuk, G., Miao, Y., Yazdany, J., Boscardin, W. J., Daikh, D. I., & Steinman, M. A.
Affiliations
  • Veterans Affairs Medical Center and University of California San Francisco
  • Veterans Affairs Medical Center San Francisco California
  • University of California San Francisco
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2014-07-28
Volume
66
Issue
8
Pages
1159-1166
ISSN
  • 2151-464X
  • 2151-4658
Cited by
69
References
2
Language
en
Funders
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR060259, AR063770)
  • National Institute on Aging (AG030999, AG036377)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.